Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Stanske M"'
Autor:
Aboelnasr, Lamia Sabry1,2 (AUTHOR) l.aboelnasr22@imperial.ac.uk, Meehan, Hannah3 (AUTHOR) hannah.meehan1@nhs.net, Saso, Srdjan1,4 (AUTHOR) srdjan.saso01@imperial.ac.uk, Yagüe, Ernesto5 (AUTHOR) ernesto.yague@imperial.ac.uk, El-Bahrawy, Mona1,6 (AUTHOR) m.elbahrawy@imperial.ac.uk
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 21, p3611. 19p.
Autor:
Guan J; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Darb-Esfahani S; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Berlin Institute of Health, Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Richter R; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Taube ET; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Berlin Institute of Health, Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Ruscito I; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Laboratory of Cell Therapy and Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Mahner S; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, University-Medical-Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany., Woelber L; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, University-Medical-Center Hamburg-Eppendorf, Hamburg, Germany., Prieske K; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, University-Medical-Center Hamburg-Eppendorf, Hamburg, Germany., Concin N; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Vergote I; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology and Obstetrics, University Hospital Leuven, Leuven, Belgium., Van Nieuwenhuysen E; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology and Obstetrics, University Hospital Leuven, Leuven, Belgium., Achimas-Cadariu P; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Surgical and Gynecological Oncology, The Oncology Institute Cluj-Napoca, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania., Glajzer J; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Woopen H; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Stanske M; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany., Kulbe H; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Denkert C; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Sehouli J; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Braicu EI; Department of Gynecology, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany. elena.braicu@charite.de.; Tumorbank Ovarian Cancer Network, Berlin, Germany. elena.braicu@charite.de.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Apr; Vol. 145 (4), pp. 1063-1073. Date of Electronic Publication: 2019 Feb 27.
Autor:
Darb-Esfahani S; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Kolaschinski I; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany., Trillsch F; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, University-Medical-Center Hamburg-Eppendorf, Hamburg, Germany., Mahner S; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, University-Medical-Center Hamburg-Eppendorf, Hamburg, Germany., Concin N; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Medical University of Innsbruck, Innsbruck, Austria., Vergote I; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology and Obstetrics, University Hospital Leuven, Leuven, Germany., Van Nieuwenhuysen E; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Gynaecological Oncology, KU Leuven, Leuven, Belgium., Achimas-Cadariu P; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Surgical and Gynecological Oncology, The Oncology Institute Cluj-Napoca, University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca, Cluj-Napoca, Romania., Glajzer J; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Charité University Hospital Berlin, Berlin, Germany., Woopen H; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Charité University Hospital Berlin, Berlin, Germany., Wienert S; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany., Taube ET; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Stanske M; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany., Kulbe H; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Charité University Hospital Berlin, Berlin, Germany., Denkert C; Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Berlin, Germany., Sehouli J; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Charité University Hospital Berlin, Berlin, Germany., Braicu EI; Tumorbank Ovarian Cancer Network, Berlin, Germany.; Department of Gynecology, Charité University Hospital Berlin, Berlin, Germany.
Publikováno v:
Histopathology [Histopathology] 2018 Dec; Vol. 73 (6), pp. 1002-1012. Date of Electronic Publication: 2018 Oct 07.
Autor:
Ruscito I; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. ilary.ruscito@uniroma1.it.; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. ilary.ruscito@uniroma1.it., Cacsire Castillo-Tong D; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria., Vergote I; Division of Gynaecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, University Hospital Leuven, Catholic University of Leuven, Herestraat 49, B-3000, Leuven, Belgium., Ignat I; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Stanske M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Vanderstichele A; Division of Gynaecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, University Hospital Leuven, Catholic University of Leuven, Herestraat 49, B-3000, Leuven, Belgium., Glajzer J; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Kulbe H; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Trillsch F; Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistrasse 15, Munich, Germany.; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 46, Hamburg, Germany., Mustea A; Department of Gynecology and Obstetrics, University Medicine of Greifswald, Greifswald, Germany., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria., Benedetti Panici P; Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Rome, Italy., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, MRC IGMM, Western General Hospital, University of Edinburgh Cancer Research, UK Centre, Crewe Road South, Edinburgh, EH4 2XR, UK., Gabra H; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.; Clinical Discovery Unit, AstraZeneca, Cambridge, UK., Nuti M; Cell Therapy Unit and Laboratory of Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Taube ET; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Kessler M; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany., Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Darb-Esfahani S; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany., Braicu EI; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Publikováno v:
British journal of cancer [Br J Cancer] 2018 Aug; Vol. 119 (3), pp. 330-338. Date of Electronic Publication: 2018 Jun 29.
Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer.
Autor:
Stanske M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: mandy.stanske@charite.de., Wienert S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany; VM Scope GmbH, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: stephanwienert@gmx.de., Castillo-Tong DC; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address: dan.cacsire-castillo@meduniwien.ac.at., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address: caroline.kreuzinger@meduniwien.ac.at., Vergote I; Department of Gynecology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Lambrechts S; Department of Gynecology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: sandrijne.lambrechts@gmail.com., Gabra H; Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, South Kensington Campus, London SW7 2AZ, UK. Electronic address: h.gabra@imperial.ac.uk., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, MRC IGMM, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK. Electronic address: charlie.gourley@ed.ac.uk., Ganapathi RN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas Health Care System, 1021 Morehead Medical Drive, Charlotte, NC 28204-2839, USA. Electronic address: ram.ganapathi@carolinashealthcare.org., Kolaschinski I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: ivonne.kolaschinski@charite.de., Budczies J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: jan.budczies@charite.de., Sehouli J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: jalid.sehouli@charite.de., Ruscito I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany; UP Cell Therapy and Tumor Immunology, Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy. Electronic address: ilary.ruscito@uniroma1.it., Denkert C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: carsten.denkert@charite.de., Kulbe H; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: hagen.kulbe@charite.de., Schmitt W; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: wolfgang.schmitt@charite.de., Jöhrens K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: korinna.joehrens@charite.de., Braicu I; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology, Augustenburger Platz 1, 13353 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: ioana@braicu.de., Darb-Esfahani S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany; Tumorbank Ovarian Cancer Network (TOC), Department of Gynecology, Charité University Hospital Berlin, Germany, Augustenburger Platz 1, 13353 Berlin, Germany. Electronic address: silvia.darb-esfahani@charite.de.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2018 Mar; Vol. 20 (3), pp. 280-288. Date of Electronic Publication: 2018 Feb 22.
Autor:
Monjé N; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Dragomir MP; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Sinn BV; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Hoffmann I; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Makhmut A; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Spatial Proteomics Group, Berlin, Germany., Simon T; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Kunze CA; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Ihlow J; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Schmitt WD; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Pohl J; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Piwonski I; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Marchenko S; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany., Keunecke C; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charitéplatz 1, 10117, Berlin, Germany., Calina TG; TGC Ventures UG, Berlin, Germany., Tiso F; Center of Functional Genomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany., Kulbe H; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charitéplatz 1, 10117, Berlin, Germany., Kreuzinger C; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Cacsire Castillo-Tong D; Translational Gynecology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Sehouli J; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charitéplatz 1, 10117, Berlin, Germany., Braicu EI; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charitéplatz 1, 10117, Berlin, Germany., Denkert C; Institute of Pathology, University Hospital Gießen and Marburg, Marburg, Germany., Darb-Esfahani S; Institute of Pathology, Berlin-Spandau, Stadtrandstraße 555, 13589, Berlin, Germany., Kübler K; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center of Functional Genomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School Teaching Hospital, Charlestown, MA, USA., Capper D; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Coscia F; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Spatial Proteomics Group, Berlin, Germany., Morkel M; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Horst D; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Sers C; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Taube ET; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Charitéplatz 1, 10117, Berlin, Germany. eliane.taube@charite.de.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 May; Vol. 130 (8), pp. 1249-1260. Date of Electronic Publication: 2024 Feb 09.
Autor:
Ruscito I; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany; Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Rome, Italy; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: ilary.ruscito@uniroma1.it., Cacsire Castillo-Tong D; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria., Vergote I; Division of Gynaecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium., Ignat I; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany., Stanske M; Institute of Pathology, Charite Medical University, Berlin, Campus Mitte, Germany., Vanderstichele A; Division of Gynaecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium., Ganapathi RN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Glajzer J; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany., Kulbe H; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany., Trillsch F; Department of Gynecology and Obstetrics, University of Munich, Marchioninistrasse 15, Munich, Germany; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 46, Hamburg, Germany., Mustea A; Department of Gynecology and Obstetrics, University Medicine of Greifswald, Greifswald, Germany., Kreuzinger C; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria., Benedetti Panici P; Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Rome, Italy., Gourley C; Nicola Murray Centre for Ovarian Cancer Research, University of Edinburgh Cancer Research UK Centre, MRC IGMM, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK., Gabra H; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Kessler M; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany., Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany., Darb-Esfahani S; Institute of Pathology, Charite Medical University, Berlin, Campus Mitte, Germany., Braicu EI; Department of Gynecology, European Competence Center for Ovarian Cancer, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Jul; Vol. 79, pp. 214-225. Date of Electronic Publication: 2017 May 16.
Autor:
Frąszczak, Karolina1 (AUTHOR) karolina.fraszczak@umlub.pl, Barczyński, Bartłomiej1 (AUTHOR) bartlomiej.barczynski@umlub.pl
Publikováno v:
Cancers. Jan2024, Vol. 16 Issue 1, p40. 28p.
Autor:
Wilczyński, Jacek R.1 (AUTHOR) jrwil@post.pl, Szubert, Maria1 (AUTHOR), Paradowska, Edyta2 (AUTHOR), Wilczyński, Miłosz3 (AUTHOR)
Publikováno v:
Cancers. Jan2023, Vol. 15 Issue 1, p111. 39p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.